We are providing innovative solutions about non-invasive genetic tests which offer excellence of technology, performance and data in the light of enhancing human life.
And with the same motivation, we are working on more relaible tests.
VERACITY, uses specifically designed and accredited internationally accredited target capture sequences(TACS) in order to avoid CNVs, repetitive elementss and complex genomic structures. This target specific approach increases sensitivity, reliability and accuracy of VERACITY by ensuring to overcome the issues other NIPTs have
Read-depth is the number of times a nucelotide in the genome is read during analysis. VERACITY captures DNA fragments only from targeted regions on chromosomes of interest. So, it is able to read these selected regions at an extremely high read-depth which improves the statistical accuracy of the analysis and increases the sensitivity and specificity of VERACITY.
VERACITY uses informative loci to reliably distinguish fetal cfDNA from maternal cfDNA. A proprietary bioinformatics software uses the high read depth counts of these informative loci to accurately calculate the fetal fraction. Accurate fetal fraction measurements raise the robustness and reliability of VERACITY.
Atatürk mah. ErtuğrulGazi Sk. 2B Metropol İstanbul C1 Blok D:235 Ataşehir/İstanbul
TELEFON : +90 216 515 36 96
E-POSTA : email@example.com